|
|
|
UNITED STATES |
|
SECURITIES AND EXCHANGE COMMISSION |
|
WASHINGTON, DC 20549 |
|
|
|
|
|
|
|
FORM 8-K |
|
|
|
|
|
|
|
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
|
THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
|
Date of Report (Date of Earliest Event Reported): July 20, 2011 |
|
|
|
|
|
|
|
Quest Diagnostics Incorporated |
|
(Exact Name of Registrant as Specified in Its Charter) |
|
|
|
|
|
|
|
Delaware |
|
(State or other jurisdiction of incorporation) |
|
|
|
|
001-12215 |
16-1387862 |
|
(Commission File Number) |
(I.R.S. Employer Identification No.) |
|
|
|
|
Three Giralda Farms |
|
|
Madison, NJ |
07940 |
|
(Address of principal executive offices) |
(Zip Code) |
(973) 520-2700
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
|
|
|
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02. Results of Operations and Financial Condition
On July 20, 2011, Quest Diagnostics Incorporated (the “Company”) issued a press release announcing, among other things, its results for the quarter ended June 30, 2011. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
Item 2.05. Costs Associated with Exit or Disposal Activities
On July 14, 2011, the Company adopted a restructuring plan that it expects to complete within the third quarter of 2011. The Company anticipates incurring a one-time charge of approximately $20 million before tax (approximately $12 million after tax) in the third quarter of 2011, principally associated with workforce reduction costs, consisting primarily of severance and related benefits. The Company expects that the full amount of the charge will result in future cash expenditures.
Item 9.01. Financial Statements and Exhibits
|
|
|
|
|
|
d. |
Exhibit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.1 |
|
Press release of Quest Diagnostics Incorporated dated July 20, 2011, announcing, among other things, its results for the quarter ended June 30, 2011. |
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
July 20, 2011
|
|
|
|
|
|
QUEST DIAGNOSTICS INCORPORATED |
|
|
|
|
|
|
|
By: |
/s/ Robert A. Hagemann |
|
|
|
|
|
|
|
Robert A. Hagemann |
|
|
|
Senior Vice President and Chief Financial |